Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2013 | 12-2012 | 10-2012 | 09-2012 | 07-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,522 | -17,354 | 730 | -11,895 | 276 |
| Depreciation Amortization | 582 | 683 | 463 | 498 | 330 |
| Income taxes - deferred | 920 | N/A | 395 | N/A | 151 |
| Accounts receivable | -414 | N/A | 1,049 | N/A | 296 |
| Accounts payable and accrued liabilities | -873 | 860 | -756 | 925 | -410 |
| Other Working Capital | -551 | 2,232 | 786 | 1,289 | -484 |
| Other Operating Activity | 8 | 443 | 304 | 1,002 | 730 |
| Operating Cash Flow | $2,194 | $-13,136 | $2,971 | $-8,181 | $889 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 615 | -5,755 | -489 | -4,821 | -303 |
| Purchase Of Investment | N/A | -32,765 | N/A | -13,515 | N/A |
| Sale Of Investment | N/A | 22,658 | N/A | 13,380 | N/A |
| Purchase Sale Intangibles | N/A | -211 | N/A | -113 | N/A |
| Other Investing Activity | 0 | -205 | 0 | -107 | 0 |
| Investing Cash Flow | $615 | $-16,067 | $-489 | $-5,063 | $-303 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,209 | 5,356 | -2,072 | 4,066 | -365 |
| Debt Repayment | -757 | -47 | -567 | -35 | -378 |
| Common Stock Issued | N/A | 23,003 | N/A | 9,268 | N/A |
| Financing Cash Flow | $-2,966 | $28,312 | $-2,639 | $13,299 | $-743 |
| Beginning Cash Position | 157 | 3,103 | 157 | 3,103 | 157 |
| End Cash Position | N/A | 2,212 | N/A | 3,158 | 0 |
| Net Cash Flow | $-157 | $-891 | $-157 | $55 | $-157 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,194 | -13,136 | 2,971 | -8,181 | 889 |
| Capital Expenditure | -780 | -5,755 | -489 | -4,821 | -303 |
| Free Cash Flow | 1,414 | -18,891 | 2,482 | -13,002 | 586 |